Contribute
España
Italia
대한민국
日本
Français
Benzinga
Research
My Stocks
Tools
Free Benzinga Pro Trial
SPY
763.140.1%
QQQ
716.510.03%
BTC/USD
78027.560.3246%
DIA
524.880.15%
GLD
402.810.13%
TLT
81.680.06%

Compass Therapeutics Inc (CMPX) Stock Price, Quote, News & History

CMPXNASDAQ
Trade with Public
Trade with Public
$2.18
-0.03-1.36%
At close: Sep 9, 5:00 PM EST
$2.20
0.02010.92%
After Hours: 7:53 PM EST
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipCompareOptionsStock Report

Compass Therapeutics (CMPX) Stock Price, Quote, News & History | Benzinga

Key Statistics

Open
$2.22
Close
$2.18
Volume / Avg.
2.61M / 2.96M
Day Range
$2.17 - $2.25
52 Wk Range
1.61 - 6.88
Market Cap
$396.21M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
45
Short Interest
26.68%
Days to Cover
9.78

Recent Compass Therapeutics Inc. News

Crude Oil Gains Over 1%; Verizon Posts Upbeat Earnings

U.S. stocks trade lower on Monday, with Dow falling 0.1%. Verizon beats Q1 earnings, raises FY26 guidance. European shares mixed, Asian markets close mixed.
Avi Kapoor

Compass Therapeutics Drops Sharply As Trial Crossover Complicates Survival Data In Bile Duct Cancer Patients

Compass Therapeutics says tovecimig misses overall survival endpoint in biliary tract cancer study, but data shows progression-free survival and response rates.
Vandana Singh

US Stocks Mixed; Nasdaq Falls Over 100 Points

US stocks mixed on Monday, Nasdaq falls 0.56% while Dow gains 0.06%. Energy shares up 1%. Domino's reports worse-than-expected results.
Avi Kapoor

Domino's Posts Downbeat Q1 Results, Joins Real Brokerage And Other Big Stocks Moving Lower In Monday's Pre-Market Session

U.S. stock futures mixed with Dow futures down 0.1%. Domino's Pizza misses earnings expectations, shares fall 3.8%. Other stocks also decline.
Avi Kapoor

Why Organon Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket

Organon & Co (OGN) jumped 14.8% in pre-market trading as Sun Pharma agreed to acquire the company for $11.75 billion, $2 higher than current price.
Avi Kapoor

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-56.11M
Investing Cash Flow (TTM)
-65.08M
Financing Cash Flow (TTM)
133.79M
Free Cash Flow (TTM)
-56.38M
Capital Expenditure (TTM)
-265.00K
Net Change in Cash (TTM)
12.60M

Analyst Trends and Forecast

1
Mar
3
Apr
1
Aug
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.4
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$227.75M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
2.40
Earnings Yield % (TTM)
-17.65%
Earnings Yield % (FWD)
-27.60%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$0.92

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$35.45M
Debt to Equity
0.06
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$2.22
Close
$2.18
Volume / Avg.
2.61M / 2.96M
Day Range
$2.17 - $2.25
52 Wk Range
1.61 - 6.88
Market Cap
$396.21M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
45
Short Interest
26.68%
Days to Cover
9.78

About

Sector
Health Care
Industry
Biotechnology
Compass Therapeutics Inc is a clinical-stage oncology-focused biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat multiple human diseases. The company's scientific focus is on the relationshi...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Compass Therapeutics (CMPX) stock?

A

You can purchase shares of Compass Therapeutics (NASDAQ:CMPX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Compass Therapeutics (CMPX) competitors?

Q

What is the forecast, or price target, for Compass Therapeutics (CMPX) stock?

A

Compass Therapeutics has a consensus price target of $11.15.

Q

What is the current price for Compass Therapeutics (CMPX)?

A

The stock price for Compass Therapeutics (NASDAQ: CMPX) is $2.2001 last updated September 9, 2026 at 7:53 PM EDT.

Q

Does Compass Therapeutics (CMPX) pay a dividend?

A

There are no upcoming dividends for Compass Therapeutics.

Q

When is Compass Therapeutics (NASDAQ:CMPX) reporting earnings?

A

Compass Therapeutics does not have any upcoming earnings scheduled.

Q

Is Compass Therapeutics (CMPX) going to split?

A

There is no upcoming split for Compass Therapeutics.

Q

What sector and industry does Compass Therapeutics (CMPX) operate in?

A

Compass Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved